Summary

Report Details

The Bioprocess Validation Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Rising Demand for Clinical Trials Globally
The market for biopharmaceuticals is rising, there is an increase in the need for healthcare due to an ageing population, and the biotech, pharmaceutical, and medical device industries are expanding to fulfil this demand. As a result, the demand for effective clinical studies has increased in order to ensure the efficacy and safety of products. Worldwide, there are around 266 thousand open clinical trials ongoing. More than 105,000 open clinical investigations are now being conducted just in the United States.

Biologics and other pharmacological medications are the focus of these trials. Positive market growth for clinical trial services has led to an uptick in finance and investment, M&A (merger and acquisition) activity, the use of CROs (contract research organisations), and the availability of functional service providers. Further variables that influence the expansion of the clinical trial services market include the FDA’s (Food and Drug Administration) recently implemented simplification of the adoption authorization process, genomics’ advancement, and the launch of medicinal products with genetic profiles that are customised to patients or diseases.

Issues Related to Extractables and Leachable
The primary objective of Extractables and Leachables (E&L) testing is to mitigate the potential safety hazards posed to consumers of various products, including pharmaceutical medications and Electronic Nicotine Delivery Systems (ENDS), by evaluating the container closure system of these products. One of the primary difficulties associated with conducting leachables studies pertains to the prevalent necessity of achieving lower detection limits. This poses a challenge for both instrument vendors and laboratory scientists.

The development of instrument methods and sample preparation techniques necessitates the involvement of proficient and knowledgeable analysts who possess advanced skills and extensive experience. This is essential in order to meet the stringent analytical evaluation thresholds. Additionally, the utilisation of cutting-edge mass spectrometry instruments and software is imperative to effectively detect these minute levels and efficiently process the resulting data.

What Questions Should You Ask before Buying a Market Research Report?
• How is the bioprocess validation market evolving?
• What is driving and restraining the bioprocess validation market?
• How will each bioprocess validation submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each bioprocess validation submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading bioprocess validation markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the bioprocess validation projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
bioprocess validation projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the bioprocess validation market?
• Where is the bioprocess validation market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the bioprocess validation market today, and over the next 10 years:
• Our 315-page report provides 113 tables and 169 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the bioprocess validation market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Test Type
• Extractable/Leachable Testing
• Microbiological Testing
• Integrity Testing
• Physiochemical Testing
• Compatibility Testing
• Others

Component
• Filters Elements
• Media Containers and Bags
• Freezing and Thawing Process Bags
• Bioreactors
• Transfer Systems
• Others

Modality
• Cell and Gene Therapy
• Vaccines
• Blood and Plasma Products
• Tissue Engineering and Regenerative Medicine
• Others

End-users
• Pharmaceutical Companies
• Biotechnology Companies
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Bioprocess Validation Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Almac Group
• Charles River Laboratories
• CMIC HOLDINGS Co., Ltd.
• Cobetter Filtration Equipment Co., Ltd.
• Cytovance Biologics
• Cytiva
• DOC S.r.l.
• Eurofins Scientific
• Lonza Group
• Meissner Filtration Products, Inc.
• Merck KGaA
• Sartorius AG
• SGS SA
• Thermo Fisher Scientific Inc.

Overall world revenue for Bioprocess Validation Market, 2023 to 2033 in terms of value the market will surpass US$490 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Bioprocess Validation Market, 2023 to 2033 report help you?
In summary, our 310+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Bioprocess Validation Market 2023 to 2033, with forecasts for test type, component, modality and end-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 22 key national markets – See forecasts for the Bioprocess Validation Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 14 of the major companies involved in the Bioprocess Validation Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Bioprocess Validation Market 2023 to 2033, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Bioprocess Validation Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Demand for Biopharmaceuticals
3.2.1.2 Increasing Demand for Outsourcing Bioprocess Validation
3.2.1.3 Rising R&D Expenditure
3.2.1.4 Rising Demand for Clinical Trials Globally
3.2.2 Market Restraining Factors
3.2.2.1 Issues Related to Extractables and Leachable
3.2.2.2 High Cost of Advanced Technology
3.2.2.3 Shortage of Skilled Labour Post COVID-19 Hampering Industry Growth
3.2.2.4 Regulatory Challenges
3.2.3 Market Opportunities
3.2.3.1 Growth Opportunities in Emerging Economies
3.2.3.2 Harmonized Bioanalytical Testing Opens New Opportunities
3.2.3.3 Data Security and Compliance in the Digital Age to Offer Lucrative Growth Prospects
3.2.3.4 Customised Solutions for Small and Medium Enterprises (SMEs)
3.2.3.5 Digital Twins for Bioprocess Validation
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors Impacting Bioprocess Validation Market
3.5.2 Economic Factors Impacting Bioprocess Validation Market
3.5.3 Social Factors Impacting Bioprocess Validation Market
3.5.4 Technological Factors Impacting Bioprocess Validation Market
3.6 Market Overview of Single-use Technologies (Bags) and Container Closure System Validation
3.7 Market Limitation of Validation Services
3.8 Decision Making Drivers for Choosing Validation Suppliers Regionally
3.9 Viral Clearance Testing Market by Region, 2023-2033 (US$ Mn, AGR %)

4 Bioprocess Validation Market Analysis by Test Type
4.1 Key Findings
4.2 Test Type Segment: Market Attractiveness Index
4.3 Bioprocess Validation Market Size Estimation and Forecast by Test Type
4.4 Extractable/Leachable Testing
4.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Microbiological Testing
4.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Integrity Testing
4.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Physiochemical Testing
4.7.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Compatibility Testing
4.8.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Others
4.9.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.9.2 Market Share by Region, 2023 & 2033 (%)

5 Bioprocess Validation Market Analysis by Component
5.1 Key Findings
5.2 Component Segment: Market Attractiveness Index
5.3 Bioprocess Validation Market Size Estimation and Forecast by Component
5.4 Filters Elements
5.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Media Containers and Bags
5.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Freezing and Thawing Process Bags
5.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Bioreactors
5.7.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Transfer Systems
5.8.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Others
5.9.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.9.2 Market Share by Region, 2023 & 2033 (%)

6 Bioprocess Validation Market Analysis by Modality
6.1 Key Findings
6.2 Modality Segment: Market Attractiveness Index
6.3 Bioprocess Validation Market Size Estimation and Forecast by Modality
6.4 Cell and Gene Therapy
6.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Vaccines
6.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Blood and Plasma Products
6.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Tissue Engineering and Regenerative Medicine
6.7.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Others
6.8.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.8.2 Market Share by Region, 2023 & 2033 (%)

7 Bioprocess Validation Market Analysis by End-users
7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 Bioprocess Validation Market Size Estimation and Forecast by End-users
7.4 Pharmaceutical Companies
7.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Biotechnology Companies
7.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Others
7.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
7.6.2 Market Share by Region, 2023 & 2033 (%)

8 Bioprocess Validation Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Bioprocess Validation Market Analysis
9.1 Key Findings
9.2 North America Bioprocess Validation Market Attractiveness Index
9.3 North America Bioprocess Validation Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 North America Bioprocess Validation Market Size Estimation and Forecast by Country
9.5 North America Bioprocess Validation Market Size Estimation and Forecast by Test Type
9.6 North America Bioprocess Validation Market Size Estimation and Forecast by Component
9.7 North America Bioprocess Validation Market Size Estimation and Forecast by Modality
9.8 North America Bioprocess Validation Market Size Estimation and Forecast by End-users
9.9 U.S. Bioprocess Validation Market Analysis
9.10 Canada Bioprocess Validation Market Analysis

10 Europe Bioprocess Validation Market Analysis
10.1 Key Findings
10.2 Europe Bioprocess Validation Market Attractiveness Index
10.3 Europe Bioprocess Validation Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Europe Bioprocess Validation Market Size Estimation and Forecast by Country
10.5 Europe Bioprocess Validation Market Size Estimation and Forecast by Test Type
10.6 Europe Bioprocess Validation Market Size Estimation and Forecast by Component
10.7 Europe Bioprocess Validation Market Size Estimation and Forecast by Modality
10.8 Europe Bioprocess Validation Market Size Estimation and Forecast by End-users
10.9 Germany Bioprocess Validation Market Analysis
10.10 UK Bioprocess Validation Market Analysis
10.11 France Bioprocess Validation Market Analysis
10.12 Italy Bioprocess Validation Market Analysis
10.13 Spain Bioprocess Validation Market Analysis
10.14 Russia Bioprocess Validation Market Analysis
10.15 Rest of Europe Bioprocess Validation Market Analysis

11 Asia Pacific Bioprocess Validation Market Analysis
11.1 Key Findings
11.2 Asia Pacific Bioprocess Validation Market Attractiveness Index
11.3 Asia Pacific Bioprocess Validation Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Asia Pacific Bioprocess Validation Market Size Estimation and Forecast by Country
11.5 Asia Pacific Bioprocess Validation Market Size Estimation and Forecast by Test Type
11.6 Asia Pacific Bioprocess Validation Market Size Estimation and Forecast by Component
11.7 Asia Pacific Bioprocess Validation Market Size Estimation and Forecast by Modality
11.8 Asia Pacific Bioprocess Validation Market Size Estimation and Forecast by End-users
11.9 Japan Bioprocess Validation Market Analysis
11.10 China Bioprocess Validation Market Analysis
11.11 India Bioprocess Validation Market Analysis
11.12 Australia Bioprocess Validation Market Analysis
11.13 South Korea Bioprocess Validation Market Analysis
11.14 South-East Asia Bioprocess Validation Market Analysis
11.15 Rest of Asia Pacific Bioprocess Validation Market Analysis

12 Latin America Bioprocess Validation Market Analysis
12.1 Key Findings
12.2 Latin America Bioprocess Validation Market Attractiveness Index
12.3 Latin America Bioprocess Validation Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Latin America Bioprocess Validation Market Size Estimation and Forecast by Country
12.5 Latin America Bioprocess Validation Market Size Estimation and Forecast by Test Type
12.6 Latin America Bioprocess Validation Market Size Estimation and Forecast by Component
12.7 Latin America Bioprocess Validation Market Size Estimation and Forecast by Modality
12.8 Latin America Bioprocess Validation Market Size Estimation and Forecast by End-users
12.9 Brazil Bioprocess Validation Market Analysis
12.10 Mexico Bioprocess Validation Market Analysis
12.11 Rest of Latin America Bioprocess Validation Market Analysis

13 MEA Bioprocess Validation Market Analysis
13.1 Key Findings
13.2 MEA Bioprocess Validation Market Attractiveness Index
13.3 MEA Bioprocess Validation Market by Country, 2023, 2028 & 2033 (US$ Million)
13.4 MEA Bioprocess Validation Market Size Estimation and Forecast by Country
13.5 MEA Bioprocess Validation Market Size Estimation and Forecast by Test Type
13.6 MEA Bioprocess Validation Market Size Estimation and Forecast by Component
13.7 MEA Bioprocess Validation Market Size Estimation and Forecast by Modality
13.8 MEA Bioprocess Validation Market Size Estimation and Forecast by End-users
13.9 GCC Bioprocess Validation Market Analysis
13.10 South Africa Bioprocess Validation Market Analysis
13.11 Rest of MEA Bioprocess Validation Market Analysis

14 Company Profiles
14.1 Sartorius AG
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.3.1 Net Revenue, 2015-2022
14.1.3.2 Regional Market Shares, 2022
14.1.3.3 R&D, 2015-2022
14.1.4 Service Benchmarking
14.1.5 Strategic Outlook
14.2 Charles River Laboratories
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2015-2022
14.2.3.2 Regional Market Shares, 2022
14.2.4 Service Benchmarking
14.2.5 Strategic Outlook
14.3 Merck KGaA
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2015-2022
14.3.3.2 Regional Market Shares, 2022
14.3.3.3 R&D, 2015-2022
14.3.4 Service Benchmarking
14.3.5 Strategic Outlook
14.4 Cytiva
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Service Benchmarking
14.4.4 Strategic Outlook
14.5 Thermo Fisher Scientific, Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2015-2022
14.5.3.2 Regional Market Shares, 2022
14.5.3.3 R&D, 2015-2022
14.5.4 Service Benchmarking
14.5.5 Strategic Outlook
14.6 SGS SA
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2015-2022
14.6.3.2 Regional Market Shares, 2022
14.6.4 Service Benchmarking
14.6.5 Strategic Outlook
14.7 Eurofins Scientific
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2016-2022
14.7.3.2 Regional Market Shares, 2022
14.7.4 Service Benchmarking
14.7.5 Strategic Outlook
14.8 Lonza Group
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2015-2022
14.8.3.2 Regional Market Shares, 2022
14.8.3.3 R&D, 2017-2022
14.8.4 Service Benchmarking
14.8.5 Strategic Outlook
14.9 Almac Group
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Service Benchmarking
14.9.4 Strategic Outlook
14.10 Cobetter Filtration Equipment Co., Ltd.
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Service Benchmarking
14.11 CMIC HOLDINGS Co., Ltd.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2015-2022
14.11.4 Service Benchmarking
14.11.5 Strategic Outlook
14.12 DOC S.r.l.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Service Benchmarking
14.13 Meissner Filtration Products, Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Service Benchmarking
14.14 Cytovance Biologics
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Service Benchmarking
14.14.4 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1 Bioprocess Validation Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Bioprocess Validation Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Bioprocess Validation Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Bioprocess Validation Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Bioprocess Validation Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Market Limitation of Validation Services
Table 1 Bioprocess Validation Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Viral Clearance Testing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 3 Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 4 Extractable/Leachable Testing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 5 Microbiological Testing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 6 Integrity Testing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Physiochemical Testing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Compatibility Testing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Bioprocess Validation Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Filters Elements Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Media Containers and Bags Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Freezing and Thawing Process Bags Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Bioreactors Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Transfer Systems Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Cell and Gene Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Blood and Plasma Products Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Tissue Engineering and Regenerative Medicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Europe Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Pharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Bioprocess Validation Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America Bioprocess Validation Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 North America Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 U.S. Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Canada Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Europe Bioprocess Validation Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Europe Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Germany Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 UK Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 France Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Italy Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Spain Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Russia Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Rest of Europe Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Asia Pacific Bioprocess Validation Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific Bioprocess Validation Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Japan Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 China Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 India Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Australia Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 South Korea Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 South-East Asia Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Rest of Asia Pacific Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Latin America Bioprocess Validation Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Latin America Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America Bioprocess Validation Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Latin America Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Brazil Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Mexico Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Rest of Latin America Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 MEA Bioprocess Validation Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 MEA Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 MEA Bioprocess Validation Market Forecast by Component, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 GCC Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 South Africa Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Rest of MEA Bioreactors Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Sartorius AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Sartorius AG: Service Benchmarking
Table 77 Sartorius AG: Strategic Outlook
Table 78 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Charles River Laboratories: Service Benchmarking
Table 80 Charles River Laboratories: Strategic Outlook
Table 81 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Merck KGaA: Service Benchmarking
Table 83 Merck KGaA: Strategic Outlook
Table 84 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Cytiva: Service Benchmarking
Table 86 Cytiva: Strategic Outlook
Table 87 Thermo Fisher Scientific, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Thermo Fisher Scientific, Inc.: Service Benchmarking
Table 89 Thermo Fisher Scientific, Inc.: Strategic Outlook
Table 90 SGS SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 SGS SA: Service Benchmarking
Table 92 SGS SA: Strategic Outlook
Table 93 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Eurofins Scientific: Service Benchmarking
Table 95 Eurofins: Strategic Outlook
Table 96 Lonza Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Lonza Group: Service Benchmarking
Table 98 Lonza Group: Strategic Outlook
Table 99 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Almac Group: Service Benchmarking
Table 101 Almac Group: Strategic Outlook
Table 102 Cobetter Filtration Equipment Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Cobetter Filtration Equipment Co., Ltd.: Service Benchmarking
Table 104 CMIC HOLDINGS Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 CMIC HOLDINGS Co., Ltd.: Service Benchmarking
Table 106 CMIC HOLDINGS Co., Ltd.: Strategic Outlook
Table 107 DOC S.r.l.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 DOC S.r.l.: Service Benchmarking
Table 109 Meissner Filtration Products, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Meissner Filtration Products, Inc.: Service Benchmarking
Table 111 Cytovance Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Cytovance Biologics: Service Benchmarking
Table 113 Cytovance Biologics: Strategic Outlook
 
List of Figures
Figure 1 Bioprocess Validation Market Segmentation
Figure 2 Bioprocess Validation Market by Test Type: Market Attractiveness Index
Figure 3 Bioprocess Validation Market by Component: Market Attractiveness Index
Figure 4 Bioprocess Validation Market by Modality: Market Attractiveness Index
Figure 5 Bioprocess Validation Market by End-users: Market Attractiveness Index
Figure 6 Bioprocess Validation Market Attractiveness Index by Region
Figure 7 Bioprocess Validation Market: Market Dynamics
Figure 8 R&D Spending of Large Pharmaceutical Companies in $ Billion, 2022
Figure 9 Number of Clinical Trials Listed in the WHO International Clinical Trials Registry Platform, by Region, 2020-2022
Figure 10 Bioprocess Validation Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 11 Bioprocess Validation Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 12 Bioprocess Validation Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 13 Bioprocess Validation Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 14 Bioprocess Validation Market Attractiveness Index by Test Type
Figure 15 Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR %)
Figure 16 Bioprocess Validation Market Share Forecast by Test Type, 2023, 2028, 2033 (%)
Figure 17 Extractable/Leachable Testing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Extractable/Leachable Testing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Microbiological Testing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Microbiological Testing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Integrity Testing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 22 Integrity Testing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Physiochemical Testing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 24 Physiochemical Testing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Compatibility Testing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Compatibility Testing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Bioprocess Validation Market Attractiveness Index by Test Type
Figure 30 Bioprocess Validation Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 31 Bioprocess Validation Market Share Forecast by Component, 2023, 2028, 2033 (%)
Figure 32 Filters Elements Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Filters Elements Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Media Containers and Bags Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Media Containers and Bags Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Freezing and Thawing Process Bags Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 37 Freezing and Thawing Process Bags Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Bioreactors Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 39 Bioreactors Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Transfer Systems Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 41 Transfer Systems Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 43 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 44 Bioprocess Validation Market Attractiveness Index by Modality
Figure 45 Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR %)
Figure 46 Bioprocess Validation Market Share Forecast by Modality, 2023, 2028, 2033 (%)
Figure 47 Cell and Gene Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Cell and Gene Therapy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 50 Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Blood and Plasma Products Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 52 Blood and Plasma Products Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Tissue Engineering and Regenerative Medicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 54 Tissue Engineering and Regenerative Medicine Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 55 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 56 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 57 Bioprocess Validation Market Attractiveness Index by End-users
Figure 58 Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 59 Bioprocess Validation Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 60 Pharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 61 Pharmaceutical Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 62 Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 63 Biotechnology Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 64 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 65 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 66 Bioprocess Validation Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 67 Bioprocess Validation Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 68 Bioprocess Validation Market by Region, 2023-2033 (US$ Mn)
Figure 69 North America Bioprocess Validation Market Attractiveness Index
Figure 70 North America Bioprocess Validation Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 71 North America Bioprocess Validation Market Forecast by Country, 2023-2033 (US$ million)
Figure 72 North America Bioprocess Validation Market Share Forecast by Country, 2023 & 2033 (%)
Figure 73 North America Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR %)
Figure 74 North America Bioprocess Validation Market Share Forecast by Test Type, 2023 & 2033 (%)
Figure 75 North America Bioprocess Validation Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 76 North America Bioprocess Validation Market Share Forecast by Component, 2023 & 2033 (%)
Figure 77 North America Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR %)
Figure 78 North America Bioprocess Validation Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 79 North America Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 80 North America Bioprocess Validation Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 81 U.S. Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 82 Canada Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 83 Europe Bioprocess Validation Market Attractiveness Index
Figure 84 Europe Bioprocess Validation Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 85 Europe Bioprocess Validation Market Forecast by Country, 2023-2033 (US$ million)
Figure 86 Europe Bioprocess Validation Market Share Forecast by Country, 2023 & 2033 (%)
Figure 87 Europe Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR %)
Figure 88 Europe Bioprocess Validation Market Share Forecast by Test Type, 2023 & 2033 (%)
Figure 89 Europe Bioprocess Validation Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 90 Europe Bioprocess Validation Market Share Forecast by Component, 2023 & 2033 (%)
Figure 91 Europe Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR %)
Figure 92 Europe Bioprocess Validation Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 93 Europe Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 94 Europe Bioprocess Validation Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 95 Germany Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 96 UK Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 97 France Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 98 Italy Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 99 Spain Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 Russia Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 Rest of Europe Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 102 Asia Pacific Bioprocess Validation Market Attractiveness Index
Figure 103 Asia Pacific Bioprocess Validation Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 104 Asia Pacific Bioprocess Validation Market Forecast by Country, 2023-2033 (US$ million)
Figure 105 Asia Pacific Bioprocess Validation Market Share Forecast by Country, 2023 & 2033 (%)
Figure 106 Asia Pacific Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR %)
Figure 107 Asia Pacific Bioprocess Validation Market Share Forecast by Test Type, 2023 & 2033 (%)
Figure 108 Asia Pacific Bioprocess Validation Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 109 Asia Pacific Bioprocess Validation Market Share Forecast by Component, 2023 & 2033 (%)
Figure 110 Asia Pacific Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR %)
Figure 111 Asia Pacific Bioprocess Validation Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 112 Asia Pacific Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 113 Asia Pacific Bioprocess Validation Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 114 Japan Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 115 China Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 116 India Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 117 Australia Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 118 South Korea Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 119 South-East Asia Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 120 Rest of Asia Pacific Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 121 Latin America Bioprocess Validation Market Attractiveness Index
Figure 122 Latin America Bioprocess Validation Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 123 Latin America Bioprocess Validation Market Forecast by Country, 2023-2033 (US$ million)
Figure 124 Latin America Bioprocess Validation Market Share Forecast by Country, 2023 & 2033 (%)
Figure 125 Latin America Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR %)
Figure 126 Latin America Bioprocess Validation Market Share Forecast by Test Type, 2023 & 2033 (%)
Figure 127 Latin America Bioprocess Validation Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 128 Latin America Bioprocess Validation Market Share Forecast by Component, 2023 & 2033 (%)
Figure 129 Latin America Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR %)
Figure 130 Latin America Bioprocess Validation Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 131 Latin America Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 132 Latin America Bioprocess Validation Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 133 Brazil Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 134 Mexico Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 135 Rest of Latin America Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 136 MEA Bioprocess Validation Market Attractiveness Index
Figure 137 MEA Bioprocess Validation Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 138 MEA Bioprocess Validation Market Forecast by Country, 2023-2033 (US$ million)
Figure 139 MEA Bioprocess Validation Market Share Forecast by Country, 2023 & 2033 (%)
Figure 140 MEA Bioprocess Validation Market Forecast by Test Type, 2023-2033 (US$ Million, AGR %)
Figure 141 MEA Bioprocess Validation Market Share Forecast by Test Type, 2023 & 2033 (%)
Figure 142 MEA Bioprocess Validation Market Forecast by Component, 2023-2033 (US$ Million, AGR %)
Figure 143 MEA Bioprocess Validation Market Share Forecast by Component, 2023 & 2033 (%)
Figure 144 MEA Bioprocess Validation Market Forecast by Modality, 2023-2033 (US$ Million, AGR %)
Figure 145 MEA Bioprocess Validation Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 146 MEA Bioprocess Validation Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 147 MEA Bioprocess Validation Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 148 GCC Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 149 South Africa Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 150 Rest of MEA Bioprocess Validation Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 151 Sartorius AG: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 152 Sartorius AG: Regional Market Shares (%), 2022
Figure 153 Sartorius AG: R&D, 2015-2022 (US$ Million, AGR%)
Figure 154 Charles River Laboratories: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 155 Charles River Laboratories: Regional Market Shares (%), 2022
Figure 156 Merck KGaA: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 157 Merck KGaA: Regional Market Shares (%), 2022
Figure 158 Merck KGaA: R&D, 2015-2022 (US$ Million, AGR%)
Figure 159 Thermo Fisher Scientific, Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 160 Thermo Fisher Scientific, Inc.: Regional Market Shares (%), 2022
Figure 161 Thermo Fisher Scientific, Inc.: R&D, 2015-2022 (US$ Million, AGR%)
Figure 162 SGS SA: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 163 SGS SA: Regional Market Shares (%), 2022
Figure 164 Eurofins Scientific: Net Revenue, 2016-2022 (US$ Million, AGR%)
Figure 165 Eurofins Scientific: Regional Market Shares (%), 2022
Figure 166 Lonza Group: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 167 Lonza Group: Regional Market Shares (%), 2022
Figure 168 Lonza Group: R&D, 2017-2022 (US$ Million, AGR%)
Figure 169 CMIC HOLDINGS Co., Ltd.: Net Revenue, 2015-2022 (US$ Million, AGR%)